PDT Partners’s Entellus Medical, Inc. Common Stock ENTL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-69,900
Closed -$1.29M 596
2017
Q3
$1.29M Buy
69,900
+19,296
+38% +$334K 0.04% 329
2017
Q2
$838K Buy
+50,604
New +$704K 0.03% 357

Other funds holding ENTL

PDT Partners's ENTL Position: Q4 2017 in Review

PDT Partners sold out of Entellus Medical, Inc. Common Stock (ENTL) in Q4 2017, closing a stake of 69,900 shares — an estimated $1.29M sold.

PDT Partners first reported a position in ENTL in Q2 2017 and held it in 2 quarters. The position peaked at $1.29M in Q3 2017. 83 funds tracked by Wall St. Rank hold ENTL as of Q4 2017.

  • PDT Partners reported no remaining Entellus Medical, Inc. Common Stock position as of Q4 2017 after selling out during the quarter.
  • PDT Partners sold 69,900 Entellus Medical, Inc. Common Stock shares in Q4 2017, an estimated $1.29M.
  • PDT Partners first reported a position in Entellus Medical, Inc. Common Stock in Q2 2017 and held it in 2 quarters.
  • PDT Partners's Entellus Medical, Inc. Common Stock position peaked at $1.29M in Q3 2017.
  • 83 funds tracked by Wall St. Rank held Entellus Medical, Inc. Common Stock as of Q4 2017.

Based on PDT Partners's 13F filing for Q4 2017, filed 14 Feb 2018.